Results 1-20 of 20 for drugs speaker:Peter Burke

Written Answers — Department of Health: Medicinal Products (24 May 2022)

Peter Burke: 660. To ask the Minister for Health if he will review the extension of kaftrio drug therapy to all children with cystic fibrosis aged 6 to11 years as in the case of a child (details supplied). [26327/22]

Tackling the Cost of Living - Institutional Investors in the Residential Property Market: Motion (15 Feb 2022)

Peter Burke: ...in our society to defray the cost of living increases. That goes from increasing the State pension at a time when inflation was not as high to more targeted measures like the fuel allowance payment and our drugs payment scheme. These support people on the front line who need that support most. On a broader base, people who are struggling like two-income families or middle-income earners...

Written Answers — Department of Health: Medicinal Products (15 Feb 2022)

Peter Burke: ...approved by the European Medicines Agency, to be made available to patients urgently requiring this treatment; the timeframe for supplying this treatment to patients; the current position of the drug in the process for approval at present; and if he will make a statement on the matter. [7848/22]

Saincheisteanna Tráthúla - Topical Issue Debate: Regeneration Projects (21 Sep 2021)

Peter Burke: ...with residents' groups to hear their concerns. There are monthly meetings with An Garda Síochána and Dublin City Council's area office and there is ongoing co-operation to investigate complaints of alleged drug distribution. All complaints are investigated. If it is a criminal matter the complainant must be referred to An Garda Síochána. If An Garda...

Written Answers — Department of Health: Health Services (24 Jun 2021)

Peter Burke: 385. To ask the Minister for Health the drug treatment programmes that are in operation for those addicted to illegal drugs in counties Longford and Westmeath; the plans there are to improve and add to these services; and if he will make a statement on the matter. [26170/21]

Written Answers — Department of Health: Medicinal Products (7 Jul 2020)

Peter Burke: 751. To ask the Minister for Health if he will examine the standard treatment plan and drug use for those suffering with stage III melanoma; if he will authorise the use of nivolumab and pembrolizumab for this condition in the public system in view of the fact it is currently the authorised treatment for this condition in the private health system; and if he will make a statement on the...

Written Answers — Department of Health: Medicinal Products (7 Jul 2020)

Peter Burke: ...Minister for Health the status of the licensing of patisiran for the effective treatment of nerve damage in view of the circumstances of a person (details supplied) and in further view of fact the drug is licensed in the UK and Northern Ireland. [14314/20]

Written Answers — Department of Health: Medicinal Products Reimbursement (14 Nov 2019)

Peter Burke: ...will be approved for reimbursement to replace tarceva for the treatment of patients with a specific type of lung cancer; if the HPRA has commissioned a review of the effectiveness of the new drug; if it will consider granting it to patients here in view of the relatively modest cost due to the small number of patients suffering with this specific form of lung cancer; if the Health Products...

Written Answers — Department of Health: Medicinal Products Reimbursement (1 Oct 2019)

Peter Burke: 414. To ask the Minister for Health the status of the application for reimbursement of the drug Tagrisso; if the NCPE will consider recommending the drug for reimbursement in the future based on the clinical need and the fact there are no other drugs available to treat this type of cancer; and if he will make a statement on the matter. [39812/19]

Written Answers — Department of Health: Drugs Payment Scheme Threshold (26 Jun 2019)

Peter Burke: 171. To ask the Minister for Health the estimated full-year cost of reducing the drug payment scheme threshold for a single-headed household to €72. [27029/19]

Written Answers — Department of Health: Medicinal Products Availability (5 Jul 2018)

Peter Burke: 236. To ask the Minister for Health the reason a person (details supplied) is still not receiving a drug; and if he will make a statement on the matter. [29875/18]

Written Answers — Department of Health: Drugs Payment Scheme Threshold (5 Dec 2017)

Peter Burke: 398. To ask the Minister for Health the estimated full-year cost of reducing the drug payment threshold to €100. [52026/17]

Written Answers — Department of Health: Drugs Payment Scheme Administration (23 May 2017)

Peter Burke: 426. To ask the Minister for Health the person or body with regulatory responsibility over pharmacies to ensure that they are correctly administrating the drug payment scheme and other prescription charges and are not charging customers for more than 12 payments of the DPS per annum; and if he will make a statement on the matter. [24011/17]

Written Answers — Department of Health: Drugs Payment Scheme Administration (5 Apr 2017)

Peter Burke: 288. To ask the Minister for Health if DPS, drugs payment scheme, patients must pay the DPS amount of €144 only 11 times per year; and if he will make a statement on the matter. [17051/17]

Written Answers — Department of Health: Drugs Payment Scheme Administration (5 Apr 2017)

Peter Burke: 289. To ask the Minister for Health the approach taken by DPS, drugs payment scheme, pharmacists when a patient runs out of medication before the calendar month is up; if there are instances where patients must pay €144 twice in one month; if this is taken into account at the end of the year in cases where patients could have made up to 14 monthly payments; and if he will make a...

Written Answers — Department of Health: Medicinal Products Availability (7 Mar 2017)

Peter Burke: 485. To ask the Minister for Health if he will order a review of the decision made by the NCPE not to fund a licensed drug which targets a genetic disorder (details supplied); and if he will make a statement on the matter. [11290/17]

Written Answers — Department of Health: Medicinal Products Licensing (13 Dec 2016)

Peter Burke: 518. To ask the Minister for Health if he will address a matter (details supplied) regarding a drug that treats ME; and if he will make a statement on the matter. [40050/16]

Written Answers — Department of Health: Medicinal Products Availability (11 Oct 2016)

Peter Burke: 452. To ask the Minister for Health if a drug that has recently come on the market in the USA will be available to persons with muscular dystrophy; and if he will make a statement on the matter. [29687/16]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (5 Jul 2016)

Peter Burke: 515. To ask the Minister for Health if he will fund the drug Ampligen for suffers of myalgic encephalomyelitis; and if he will make a statement on the matter. [19325/16]